Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Globenewswire -
Nổi bật :
Alvotech Announces Webcast of 2022 Full Year Financial
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced...
MỚI NHẤT
![[Mới] Bật mí số may mắn 12 con giáp năm 2025 để tăng tài lộc](http://cdn.trangcongnghe.vn/thumb/70x70/2025-01/mi-bt-mi-s-may-mn-12-con-giap-nm-2025-tng-tai-lc-1.jpg)
QUAN TÂM
